I. Schellschmidt

发表

Different Pearl Indices in studies of hormonal contraceptives in the United States: impact of study population.

C. Gerlinger, J. Trussell, J. Endrikat, 2014, Contraception.

A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena.

D. Apter, K. Gemzell‐Danielsson, I. Schellschmidt, 2012, Fertility and sterility.

Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate

E. Palombo-Kinne, T. Gräser, B. Rushforth, 2009, Journal of Family Planning and Reproductive Health Care.

Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment.

H. Gollnick, I. Schellschmidt, lan H Thorneycroft, 2004, Cutis.

An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations.

E. Nieschlag, S. von Eckardstein, A. Kamischke, 2002, The Journal of clinical endocrinology and metabolism.

Suppression of ovarian activity with a low-dose 21/7-day regimen oral contraceptive containing ethinylestradiol 20 mcg/drospirenone 3 mg in Japanese and Caucasian women.

D. Heger-Mahn, Y. Anzai, J. Marr, 2012, Contraception.

Original research article Suppression of ovarian activity with a low-dose 21/7-day regimen oral contraceptive containing ethinylestradiol 20 mcg/drospirenone 3 mg in Japanese and Caucasian women ☆

D. Heger-Mahn, Y. Anzai, J. Marr, 2012 .

Optimal dose de-escalation trial designs for novel contraceptives in women

Christoph Gerlinger, Oke Gerke, Jan Endrikat, 2012, Comput. Stat. Data Anal..

The use of an oral contraceptive containing ethinylestradiol and drospirenone in an extended regimen over 126 days.

J. Foidart, P. Sulak, I. Schellschmidt, 2006, Contraception.

Rate of Pregnancy After Using Drospirenone and Other Progestin-Containing Oral Contraceptives

J. Dinger, I. Schellschmidt, M. Cronin, 2009, Obstetrics and gynecology.

EVAPIL-R Scale: Continuous development and validation of a tool to assess patient-reported tolerability of different contraceptive methods in longitudinal studies.

P. Clerson, O. Graesslin, A. Filonenko, 2014, Clinical therapeutics.

Sebum production was determined at baseline , cycle 3 , and cycle 6 by using a photometry

H. Gollnick, I. Thorneycroft, I. Schellschmidt, 2004 .

Oral contraceptive effectiveness according to body mass index, weight, age, and other factors.

C. Westhoff, J. Dinger, S. Möhner, 2009, American journal of obstetrics and gynecology.

Prognostic significance of DNA content and S-phase fraction in epithelial ovarian carcinomas analyzed by image cytometry.

A. Reles, A. Schmider, M. Press, 1998, Gynecologic oncology.